Layla N. Van Doren, MD

Dr. Van Doren’s clinical practice focuses on the diagnosis and management of bleeding and clotting disorders, with a special emphasis in women’s health. She has a particular expertise in pregnancy-related hematologic disorders, such as anemia and thrombocytopenia in pregnancy, hemolytic disease of the fetus (HDFN), and neonatal alloimmune thrombocytopenia (NAIT). She is also an expert in difficult-to-manage blood disorders, including antiphospholipid antibody syndrome (APLS), heparin-induced thrombocytopenia (HIT), immune thrombocytopenic purpura (ITP), autoimmune hemolytic anemia (AIHA), and thrombotic thrombocytopenic purpura (TTP).

Dr. Van Doren received her medical degree from the George Washington University School of Medicine and Health Sciences. She completed her residency at University of Southern California/ Los Angeles County. She went on to complete her Hematology & Oncology fellowship at Tufts Medical Center in Boston, where she served as chief fellow from 2017-2019. As a research fellow in the lab of Lidija Covic, PhD, in the Hemostasis and Thrombosis Laboratory, Dr. Van Doren established a mechanistic framework and validated the pathophysiologic and therapeutic relevance of the lipid receptor GPR31 during PAR4-depedant platelet activation.

Dr. Van Doren is a member of the American Society of Hematology and the International Society of Thrombosis and Hemostasis. She has authored peer-reviewed publications, and has spoken at conferences, including the annual American Society of Hematology meeting.